thiorphan has been researched along with Cardiovascular Diseases in 3 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wegner, M | 1 |
| Stasch, JP | 1 |
| Hirth-Dietrich, C | 1 |
| Dressel, J | 1 |
| Voges, KP | 1 |
| Kazda, S | 1 |
| Wilkins, MR | 1 |
1 review available for thiorphan and Cardiovascular Diseases
| Article | Year |
|---|---|
Clinical potential of endopeptidase-24.11 inhibitors in cardiovascular disease.
Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Cyclohexanecarboxylic Acids; Diuretics; D | 1993 |
2 other studies available for thiorphan and Cardiovascular Diseases
| Article | Year |
|---|---|
Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.
Topics: Animals; Atrial Natriuretic Factor; Cardiovascular Diseases; Cyclic GMP; Diuresis; Dogs; Drug Intera | 1995 |
Ecadotril. (S)-acetorphan, sinorphan.
Topics: Animals; Cardiovascular Diseases; Drugs, Investigational; Endopeptidases; Heart Failure; Humans; Hyp | 1999 |